Current Evidence and Recommendations for Rate Control in Atrial Fibrillation

Arrhythmia & Electrophysiology Review
Abhishek MaanE Kevin Heist

Abstract

Atrial fibrillation (AF) is the most common cardiac arrhythmia encountered in clinical practice, which is associated with substantial risk of stroke and thromboembolism. As an arrhythmia that is particularly common in the elderly, it is an important contributor towards morbidity and mortality. Ventricular rate control has been a preferred and therapeutically convenient treatment strategy for the management of AF. Recent research in the field of rhythm control has led to the advent of newer antiarrhythmic drugs and catheter ablation techniques as newer therapeutic options. Currently available antiarrhythmic drugs still remain limited by their suboptimal efficacy and significant adverse effects. Catheter ablation as a newer modality to achieve sinus rhythm (SR) continues to evolve, but data on long-term outcomes on its efficacy and mortality outcomes are not yet available. Despite these current developments, rate control continues to be the front-line treatment strategy, especially in older and minimally symptomatic patients who might not tolerate the antiarrhythmic drug treatment. This review article discusses the current evidence and recommendations for ventricular rate control in the management of AF. We also highlight the con...Continue Reading

Citations

Sep 15, 2016·Scandinavian Journal of Gastroenterology·Espen Skarstein KolbergAstrid Rydning
Jun 23, 2018·Physiological Reports·Nishi H PatelHarpreet Singh
Apr 17, 2020·Frontiers in Cardiovascular Medicine·Pim R R van GorpAntoine A F de Vries
Jun 16, 2021·Circulation. Arrhythmia and Electrophysiology·Rakesh GopinathannairUNKNOWN American Heart Association Electrocardiography and Arrhythmias Committee and Heart Failure and Transplantation Committee of

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Related Papers

Journal of Cardiovascular Pharmacology and Therapeutics
Malini GovindanA John Camm
Expert Review of Cardiovascular Therapy
Sandeep AroraKomandoor Srivathsan
Cardiac Electrophysiology Clinics
Eric BuchKalyanam Shivkumar
The American Journal of Medicine
Jason S ChinitzValentin Fuster
© 2021 Meta ULC. All rights reserved